Relationship between Decrease in Urine Output following Treatment with Prostaglandin Inhibitors and PDA Closure.

Area of Science:

• Neonatal Physiology
• Pharmacology
• Pediatric Cardiology

Background:

• Prostaglandin inhibitors are standard treatment for patent ductus arteriosus (PDA) in preterm infants.
• These inhibitors can cause a transient decrease in urine output (UO) due to effects on renal vasculature.
• The relationship between this UO change and PDA closure efficacy is not well-established.

Purpose of the Study:

• To investigate the association between decreased urine output (UO) and successful closure of hemodynamically significant PDA (hsPDA).
• To determine if renal vascular sensitivity to prostaglandin inhibitors correlates with ductal tissue sensitivity.
• To identify if reduced UO predicts PDA closure in preterm neonates.

Main Methods:

• Prospective, proof-of-concept cohort study involving 40 preterm neonates with hsPDA treated with prostaglandin inhibitors.
• Daily measurement of urine output (UO) from baseline up to 72 hours.
• Daily echocardiography to assess PDA status; comparison of UO changes between PDA-closed and PDA-open groups.

Main Results:

• The PDA-closed group (n=28) exhibited a significantly greater percentage decrease in UO compared to the PDA-open group (n=12) at multiple time points (24-48h and 48-72h).
• The decrease in UO preceded PDA closure, and was associated with greater weight loss in the PDA-closed group.
• A decrease in UO of 27% (24-48h) and 17% (48-72h) best predicted PDA closure.

Conclusions:

• A reduction in urine output following prostaglandin inhibitor treatment for hsPDA is significantly associated with successful PDA closure.
• This suggests that the degree of UO reduction can serve as a predictive marker for treatment efficacy.
• Further research may elucidate the underlying mechanisms linking renal and ductal responses to prostaglandin inhibition.